EMST with SpiroGym app for Parkinson's (NCT06942533)
Improve cough strength with feedback
- Trial ID
- NCT06942533
- Official Title
- The Effect of Visual Feedback From the SpiroGym Mobile Application on Expiratory Muscle Strength Training Performance in Patients With Parkinson's Disease
- Goal
- Improve cough strength with feedback
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- General University Hospital, Prague
- Study Type
- INTERVENTIONAL
- Enrollment
- 30 participants
- Conditions
- Parkinson Disease, Breathing Exercises, Telemedicine
- Interventions
- EMST with SpiroGym app, EMST without SpiroGym app
Summary For Families
Researchers want to know whether adding visual feedback from the SpiroGym mobile app makes expiratory muscle training more effective for people with Parkinson's, building on a pilot that found two weeks of this training improved cough strength (peak cough flow). Participants will do two supervised training sessions that push out air against a set resistance at 75% of their maximum breath-out pressure, once with the SpiroGym app showing visual feedback and once without, in random order with two weeks between sessions; the team will compare muscle activity measured by sensors on the skin, the loudness recorded by the app, and participants' ratings of difficulty and motivation. The trial is looking for men and women age 40 to 80 with Parkinson's who have had a stable dopamine medication dose for at least one month, and it excludes people with other neurological conditions, major psychiatric illness, significant memory problems, prior head or neck cancer or neck surgery, or those who are ill during the study.
Locations
- General University Hospital, Prague, Czechia
- Department of Neurology and Centre of Clinical Neuroscience First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czechia
Frequently Asked Questions
- What is this trial testing?
- This trial is studying EMST with SpiroGym app. Researchers want to know whether adding visual feedback from the SpiroGym mobile app makes expiratory muscle training more effective for people with Parkinson's, building on a pilot that found two weeks of this training improved cough strength (peak cough flow). Participants will do two supervised training sessions that push out air against a set resistance at 75% of their maximum breath-out pressure, once with the SpiroGym app showing visual feedback and once without, in random order with two weeks between sessions; the team will compare muscle activity measured by sensors on the skin, the loudness recorded by the app, and participants' ratings of difficulty and motivation. The trial is looking for men and women age 40 to 80 with Parkinson's who have had a stable dopamine medication dose for at least one month, and it excludes people with other neurological conditions, major psychiatric illness, significant memory problems, prior head or neck cancer or neck surgery, or those who are ill during the study.
- Who can participate?
- Participants must be between 40 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 2 locations.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 1 year.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- This is a crossover trial: instead of staying in one group, you move through a sequence of assignments, so you receive the active treatment during at least one period of the study. Ask the coordinator for the exact sequence and how long each phase lasts.
- How many visits does this trial involve?
- You will attend two EMST sessions separated by a two-week interval.